MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
36 hedge funds and large institutions have $20.7M invested in Merrimack Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
36
Holding in Top 10
–
Calls
$367K
Puts
–
Top Buyers
| 1 | +$88.1K | |
| 2 | +$88K | |
| 3 | +$25K | |
| 4 |
BlackRock
New York
|
+$10K |
| 5 |
WR
Watson Rebecca
|
+$10K |
Top Sellers
| 1 | -$477K | |
| 2 | -$188K | |
| 3 | -$149K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$140K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$126K |